Denali Capital Acquisition Corp. Files SC 13D for Scilex Holding Co.

Ticker: SMNRW · Form: SC 13D · Filed: Sep 9, 2024 · CIK: 1913577

Denali Capital Acquisition Corp. SC 13D Filing Summary
FieldDetail
CompanyDenali Capital Acquisition Corp. (SMNRW)
Form TypeSC 13D
Filed DateSep 9, 2024
Risk Levelmedium
Pages6
Reading Time7 min
Key Dollar Amounts$0.0001, $2,000,000
Sentimentneutral

Sentiment: neutral

Topics: ownership-change, sec-filing, sc-13d

TL;DR

**Denali Capital Acquisition Corp. just filed a 13D on Scilex Holding Co. Big ownership change incoming?**

AI Summary

On September 9, 2024, Denali Capital Acquisition Corp. filed an SC 13D, indicating a change in beneficial ownership. The filing pertains to Scilex Holding Co., with Jaisim Shah, CEO of Scilex Holding Company, listed as a key individual. The filing was made as of September 9, 2024.

Why It Matters

This filing signals a potential shift in control or significant investment in Scilex Holding Co. by Denali Capital Acquisition Corp., which could impact the company's strategic direction and stock performance.

Risk Assessment

Risk Level: medium — SC 13D filings often precede significant corporate actions or changes in control, introducing uncertainty and potential volatility.

Key Players & Entities

FAQ

What is the primary purpose of this SC 13D filing?

The filing indicates a change in beneficial ownership of Scilex Holding Co. by Denali Capital Acquisition Corp.

Who is Jaisim Shah in relation to this filing?

Jaisim Shah is identified as the Chief Executive Officer of Scilex Holding Company.

What is the CUSIP number for the securities involved?

The CUSIP number listed for Class A Ordinary Shares of Denali Capital Acquisition Corp. is G6256B106.

When was this filing made?

The filing was made as of date September 9, 2024.

What is the business address of Denali Capital Acquisition Corp.?

The business address for Denali Capital Acquisition Corp. is 437 Madison Avenue, 27th Floor, New York, NY 10022.

Filing Stats: 1,833 words · 7 min read · ~6 pages · Grade level 11.9 · Accepted 2024-09-09 16:11:56

Key Financial Figures

Filing Documents

From the Filing

SC 13D 1 d67878dsc13d.htm SC 13D SC 13D UNITED STATES SECURITIES & EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* Denali Capital Acquisition Corp. (Name of Issuer) Class A Ordinary Shares, $0.0001 par value per share (Title of Class of Securities) G6256B106 (CUSIP Number) Jaisim Shah Chief Executive Officer Scilex Holding Company 960 San Antonio Road Palo Alto, CA 94303 (650) 516-4310 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 30, 2024 (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 13d-7(b) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.: G6256B106 1. NAME OF REPORTING PERSON Scilex Holding Company 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)(b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (SEE INSTRUCTIONS) PF, OO 5. CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7. SOLE VOTING POWER 500,000 (1) 8. SHARED VOTING POWER 0 9. SOLE DISPOSITIVE POWER 500,000 (1) 10. SHARED DISPOSITIVE POWER 0 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 500,000 (1) 12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 39.9% (2) 14. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO (1) Comprised of 500,000 Class B Ordinary Shares, par value $0.0001 per share ( Class B Ordinary Shares ), of Denali Capital Acquisition Corp. (the Issuer ) held directly by the Reporting Person (as defined herein), which will automatically convert into Class A Ordinary Shares, par value $0.0001 per share ( Class A Ordinary Shares ), of the Issuer concurrently with or immediately following the consummation of the Issuers initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. (2) Percent of class beneficially owned is calculated based on the sum of: (i) 751,837 Class A Ordinary Shares outstanding as of August 19, 2024, as reported in the Issuers Form 10-Q for the quarter ended June 30, 2024 filed with the Securities and Exchange Commission on August 19, 2024; and (ii) the 500,000 Class A Ordinary Shares issuable to the Reporting Person upon conversion of the 500,000 Class B Ordinary Shares held directly by the Reporting Person, which Class A Ordinary Shares have been added to the total Class A Ordinary Shares outstanding in accordance with Rule 13d-3(d)(1)(i) under the Act. ITEM1. Security and Issuer. The securities to which this Schedule 13D relates are the Class A Ordinary Shares of the Issuer. The principal executive offices of the Issuer are located at 437 Madison Avenue, 27 th Floor, New York, New York 10022 United States. ITEM2. Identity and Background. This Schedule 13D is being filed by Scilex Holding Company (the Reporting Person or Scilex ). The Reporting Person is a Delaware corporation, with its principal place of business at 960 San Antonio Road, Palo Alto, CA 94303. The principal business of the Reporting Person is biopharmaceutical products. Information regarding the identity and background of each executive officer and director of the Reporting Person is set forth on Schedule A to this Schedule 13D. Each of the individuals identified on Schedule A to this Schedule 13D is a U.S. citizen. None of the Reporting Person, or, to the Reporting Persons knowledge, any individuals identified on Schedule A to this Schedule 13D has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). None of the Reporting Person, or, to the Reporting Persons knowledge, any individuals identified on Schedule A to this Schedule 13

View Full Filing

View this SC 13D filing on SEC EDGAR

View on Read The Filing